Ono Pharma Partners With Aitia on Causal AI Drug Discovery
OSAKA, Japan and CAMBRIDGE, Mass., September 2, 2026 Ono Pharmaceutical Co., Ltd. has entered into a drug discovery partnership...
pharmaceutical R&D
Advertisement
Kirin Advances AI-Native Research With GenerativeX
Tokyo, Japan, August 5, 2026 Kirin Holdings Co., Ltd. and GenerativeX Inc. have launched a new research model that...
Insilico and THPharm Expand AI Drug Development Strategy
Seoul, South Korea, August 12, 2026 THPharm is advancing an artificial intelligence-driven indication expansion strategy in partnership with Insilico...
WindRose Recapitalizes Verified Clinical Trials to Fuel Growth
New York, August 6, 2026 WindRose Health Investors, LLC has completed the recapitalization of Verified Clinical Trials, LLC (VCT),...
GSK Invests £400M in Cambridge R&D Innovation Centre
LONDON, July 30, 2026 GSK has announced plans to establish a new global flagship research and development (R&D) centre...
Advertisements
Insilico Medicine and CMS Expand AI Collaboration for CNS Therapies
HONG KONG, China, July 12, 2026 Insilico Medicine, a clinical-stage biotechnology company powered by generative artificial intelligence (AI), and...
Rancho BioSciences Launches OmicsHQ for AI Drug Discovery
SAN DIEGO, Calif., May 19, 2026 Rancho BioSciences has officially launched OmicsHQ™, a comprehensive and expertly curated multi-omics data...
Thermo Fisher Opens Cryo-EM Drug Discovery Center in SF
March 05, 2026 — South San Francisco, California, USA Global life sciences leader Thermo Fisher Scientific has announced the...
Havih–India Partnership Expands BSL-4 Pharma R&D
HYDERABAD, India, Dec. 17, 2025 — Havih Envirosciences, a subsidiary of Maxwell Biosciences, announced a strategic partnership with the...
Gan & Lee Starts Phase 3 Trial of Once-Monthly GLP-1 Therapy
BEIJING — November 27, 2025. Gan & Lee Pharmaceuticals has initiated GRADUAL-3, its third Phase 3 clinical study evaluating...
Advertisement
